Myomo (MYO) EBT Margin Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,577.00 |
| Jun 30, 2025 | 3,282.00 |
| Mar 31, 2025 | 3,695.00 |
| Dec 31, 2024 | 12,758.00 |
| Sep 30, 2024 | 3,683.00 |
| Jun 30, 2024 | 7,054.00 |
| Mar 31, 2024 | 2,554.00 |
| Dec 31, 2023 | -12,690.00 |
| Sep 30, 2023 | 10,502.00 |
| Jun 30, 2023 | 36,562.00 |
| Mar 31, 2023 | 30,158.00 |
| Dec 31, 2022 | 10,409.00 |
| Sep 30, 2022 | 38,890.00 |
| Jun 30, 2022 | 21,212.00 |
| Mar 31, 2022 | 24,219.00 |
| Dec 31, 2021 | 27,013.00 |
| Sep 30, 2021 | 39,091.00 |
| Jun 30, 2021 | 33,231.00 |
| Mar 31, 2021 | 62,828.00 |
| Dec 31, 2020 | 260,081.00 |
| Sep 30, 2020 | 15,855.00 |
| Jun 30, 2020 | 29,542.00 |
| Mar 31, 2020 | 790,160.00 |
| Dec 31, 2019 | 20,919.00 |
| Sep 30, 2019 | 152.00 |
| Jun 30, 2019 | -4,845.00 |